These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 27225507)

  • 21. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
    Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS).
    Dabas S; Gupta K; Sharma AK; Shukla H; Ranjan R; Sharma DK
    Eur J Surg Oncol; 2019 Nov; 45(11):2137-2142. PubMed ID: 31239156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
    Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
    J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma.
    Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH
    Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
    Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
    Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
    Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery.
    Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D
    J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
    Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer.
    Sher DJ; Fidler MJ; Tishler RB; Stenson K; al-Khudari S
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):512-22. PubMed ID: 26867880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
    Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
    Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV/p16-positive oropharyngeal cancer treated with transoral robotic surgery: The roles of margins, extra-nodal extension and adjuvant treatment.
    Nichols DS; Zhao J; Boyce BJ; Amdur R; Mendenhall WM; Danan D; Hitchcock K; Ning K; Keyes K; Lee JH; Dziegielewski PT
    Am J Otolaryngol; 2021; 42(1):102793. PubMed ID: 33130532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of human papillomavirus and smoking on survival outcomes after transoral robotic surgery.
    Stucken CL; de Almeida JR; Sikora AG; Tong CC; Genden EM
    Head Neck; 2016 Mar; 38(3):380-6. PubMed ID: 25351893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
    Cramer JD; Ferris RL; Kim S; Duvvuri U
    Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes.
    Quon H; Cohen MA; Montone KT; Ziober AF; Wang LP; Weinstein GS; O'Malley BW
    Laryngoscope; 2013 Mar; 123(3):635-40. PubMed ID: 22588642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
    Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
    Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.
    Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E
    Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.